Enzymatica publ AB (ENZY) — Cash Flow-to-Debt Ratio
Enzymatica publ AB (ENZY) has a Cash Flow-to-Debt Ratio of -0.85x as of September 2025, meaning its operating cash flow of Skr-11.57 Million could theoretically repay -1% of its total liabilities (Skr13.56 Million) in one year. See Enzymatica publ AB leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Enzymatica publ AB Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Enzymatica publ AB across 15 annual periods. For the full cash flow conversion analysis, see Enzymatica publ AB operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Enzymatica publ AB (2009–2024)
Year-by-year debt coverage analysis for Enzymatica publ AB. Check ENZY cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.21x | Skr-60.51 Million | Skr18.86 Million | ▼ -292.7% |
| 2023 | -0.82x | Skr-40.29 Million | Skr49.30 Million | ▲ +39.1% |
| 2022 | -1.34x | Skr-64.57 Million | Skr48.12 Million | ▼ -20.0% |
| 2021 | -1.12x | Skr-35.87 Million | Skr32.07 Million | ▼ -481.5% |
| 2020 | -0.19x | Skr-10.65 Million | Skr55.38 Million | ▲ +85.4% |
| 2019 | -1.32x | Skr-37.58 Million | Skr28.51 Million | ▼ -16.8% |
| 2018 | -1.13x | Skr-28.79 Million | Skr25.51 Million | ▼ -15.8% |
| 2017 | -0.97x | Skr-22.55 Million | Skr23.12 Million | ▲ +47.7% |
| 2016 | -1.87x | Skr-38.43 Million | Skr20.60 Million | ▼ -8.4% |
| 2015 | -1.72x | Skr-37.65 Million | Skr21.87 Million | ▲ +58.8% |
| 2014 | -4.17x | Skr-40.67 Million | Skr9.74 Million | ▼ -133.1% |
| 2013 | -1.79x | Skr-18.43 Million | Skr10.29 Million | ▲ +51.5% |
| 2012 | -3.69x | Skr-7.25 Million | Skr1.96 Million | ▼ -1.2% |
| 2011 | -3.65x | Skr-4.86 Million | Skr1.33 Million | ▼ -7501.7% |
| 2009 | -0.05x | Skr-101.99K | Skr2.12 Million | — |